Overview
Edward Creagan is an Oncologist in Rochester, Minnesota. His top areas of expertise are Lung Adenocarcinoma, EGFR Positive Lung Cancer, ALK-Positive Non-Small Cell Lung Cancer, and Small Cell Lung Cancer (SCLC).
His clinical research consists of co-authoring 10 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
200 1st St SW, Rochester, MN 55905
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MN - Cancer
Stephen Ansell is a Hematologist and an Oncologist in Rochester, Minnesota. Dr. Ansell is highly rated in 25 conditions, according to our data. His top areas of expertise are Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Transplant, and Tissue Biopsy.
MN - Cancer Transplant
Francis Buadi is a Hematologist and an Oncologist in Rochester, Minnesota. Dr. Buadi is highly rated in 12 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Primary Amyloidosis, Smoldering Multiple Myeloma, POEMS Syndrome, and Bone Marrow Transplant.
MN - Cancer
Thorvardur Halfdanarson is an Oncologist in Rochester, Minnesota. Dr. Halfdanarson is highly rated in 26 conditions, according to our data. His top areas of expertise are Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatic Cancer, Pancreaticoduodenectomy, and Hepatectomy.
Frequently Asked Questions about Dr. Edward Creagan
How do I make an appointment with Dr. Edward Creagan?
You can book an appointment with Dr. Edward Creagan by calling their office at 507-284-8413. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Edward Creagan a top-rated expert for Lung Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Edward Creagan is classified as an Experienced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Edward Creagan specialize in?
While Dr. Edward Creagan is a Oncology, they have specific expertise in Lung Adenocarcinoma, EGFR Positive Lung Cancer, and ALK-Positive Non-Small Cell Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Edward Creagan participate in research or clinical trials?
Yes. Dr. Edward Creagan has published 10 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Dr. Edward Creagan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Creagan isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Creagan isExperienced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Creagan isExperienced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Creagan isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Creagan isExperienced. Learn about Lung Cancer.
- MelanomaDr. Creagan isExperienced. Learn about Melanoma.